BioLife Solutions Inc (BLFS) — Capital Reinvestment Ratio

Latest as of December 2025: 0.43x

BioLife Solutions Inc (BLFS) has a Capital Reinvestment Ratio of 0.43x as of December 2025, meaning it reinvests 0% of its operating cash flow ($4.92 Million) in capital expenditures ($2.09 Million). See BLFS net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.43x
Capex / Operating Cash Flow

Operating Cash Flow

$4.92 Million
USD

Capital Expenditures

$2.09 Million
USD

Data as of

Dec 2025
Most recent filing

BioLife Solutions Inc Capital Reinvestment Ratio (1998–2025)

This chart tracks BioLife Solutions Inc's Capital Reinvestment Ratio across 10 annual periods. Check BLFS cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for BioLife Solutions Inc (1998–2025)

Year-by-year Capital Reinvestment Ratio for BioLife Solutions Inc from 1998 to 2025. For live market cap and broader valuation context, see market value of BioLife Solutions Inc.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.47x $20.11 Million $9.48 Million ▲ +23.1%
2024 0.38x $8.43 Million $3.23 Million ▼ -46.2%
2020 0.71x $6.51 Million $4.63 Million ▲ +27.8%
2019 0.56x $1.21 Million $675.00K ▲ +161.3%
2018 0.21x $2.35 Million $500.00K ▼ -10.4%
2017 0.24x $605.00K $143.77K ▼ -85.3%
2013 1.62x $146.01K $236.67K ▲ +20.3%
2012 1.35x $854.93K $1.15 Million ▲ +954.6%
2004 0.13x $515.10K $65.80K ▼ -98.5%
1998 8.57x $29.12K $249.62K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow